1 active not recruiting, 1 completed. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) YOLT-202 - Alpha-1 Antitrypsin Deficiency (AATD) | Early Phase 1 | Active not recruiting | RenJi Hospital | 18 | 2025-06-18 | 2025-09-26 |
| Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency rAAV2-CB-hAAT Gene Vector - Alpha 1-Antitrypsin Deficiency | Early Phase 1 | Completed | University of Massachusetts, Worcester | 12 | 2004-03-01 | 2020-04-10 |
alpha 1-Antitrypsin Deficiency (2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Emphysema (2) · Genetic Diseases, Inborn (2) · Liver Diseases (2) · Lung Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2)
RenJi Hospital (1) · University of Massachusetts, Worcester (1)
China (1) · United States (1)
R01HL069877 (1)